MRA 2017-2018 Request for Proposals

The Melanoma Research Alliance (MRA) announces a Request for Proposals (RFP) soliciting high-impact pre-clinical, translational, and early clinical research from scientists and clinicians around the world. The RFP calls for ideas that have the potential to lead to near-term clinical application in melanoma prevention, detection, diagnosis, staging, and treatment.

Proposals will be accepted for Young Investigator Awards, Team Science Awards, and Academic-Industry Partnership Awards (for Established Investigators). Please note that two Special Opportunities are available: 

  • Special Opportunity Women in Scientific Research Young Investigator Award
  • Rising Tide Foundation for Clinical Cancer Research (RTFCCR)-MRA Team Science Award for European-led Teams

October 6, 2017: Deadline for Team Science Award Letters of Intent including the RTFCCR-MRA European-led Team Science Award

November 17, 2017: Deadline for Young Investigator Award and Academic Industry-Partnership Award proposals

January 9, 2018: Deadline for meritorious Team Science Award full-length proposals

Full descriptions of each award opportunity offered, including the just-announced Special Opportunity Award for European-led Teams, as well as eligibility criteria and instructions can be found in the Second Release MRA 2017-2018 RFP document:

Second Release MRA 2017-2018 Request for Proposals

MRA Award Terms and Conditions 

Questions: 

Tasheema Prince, MRA Scientific Program Manager  

tprince@curemelanoma.org

About Melanoma

Melanoma is a leading cause of new cancers, and more effective options for patients and those at risk are urgently needed. Recent scientific and clinical advances have provided new hope, but much work remains to be done to end suffering and death from melanoma.

Login

×